Healthcare


Recent Diagnostic and Therapeutic Advances Across the Global Biotech Landscape

Share this:
     
Published: 2 Mar 2018

This edition of the Genetic Technology TOE depicts new life sciences trends across diagnostics and therapeutics. Different diagnostic approaches including liquid biopsy tests for autism and related disorders are illustrated along with a number of therapeutic innovations for neurodegenerative diseases. The recent advances in personalized medicine initiatives in oncology and the consequent progress across the immuno-oncology pipeline are also included. The corresponding clinical trials scenario is also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Biopsy, autism disorder, neurodegenerative disorders, personalized medicine, immuno-oncology, precision medicine

  1.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..